Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CANVIVA is a private U.S. hemp wellness company that sells full-spectrum CBD, CBG, and CBN consumer products, primarily tinctures, topicals, and pet products. The company positions itself as a quality-focused, non-psychoactive plant-based therapy brand using U.S.-grown organic hemp, third-party testing, and its PURE CERTIFIED CANNABINOIDS quality standard. CANVIVA launched from C4Life and markets condition-oriented formulations for sleep, stress, muscle support, focus, digestive support, and sports recovery rather than traditional prescription therapeutics. Its business appears centered on direct-to-consumer commercialization and retail-style wellness branding rather than regulated drug development. The company is based in the Minneapolis, Minnesota area and remains privately held.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CANVIVA.